ICICI Securities research report on Insecticides India
Takeaways from Q4FY20: (1) Disposal of generics inventory resulted in lower realizations and impacted gross margin (740bps YoY decline), (2) The company has focussed on reducing net working capital and debt which is good for long term health of the company and (3) Agrochemical markets is doing well with (i) additional demand for herbicides due to labour shortage and (ii) increase in insecticides consumption due to locust pest attack after 26 years. We remain positive on Insecticides due to (1) steady launches of high-margin products, (2) removal of generic products from the portfolio and (3) backward integration of technical. The stock is trading close to 1-year forward ‘mean P/E - 1SD’.
Outlook
Return ratios are above cost of capital; hence, we believe the risk:reward is favourable. Maintain BUY with a target price of Rs700 (10x FY22E, Earlier TP-Rs832).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.